Warren B. Seiler III, MD
John Di Saia, MD
Beatriz H. Porras, MD
Shervin Naderi, MD, FACS
Edward Zimmerman MD
Paula Di Marco Young, BS RN
Seth A. Yellin, MD FACS
Dr. Kevin D. Light
Stephen Weber MD PhD
Brian K. Sidella
Sabine Zenker, MD
Daniel Kaufman MD
Brian Howard MD FACS
Mickey A. Couvertier
Lila Bratani MD
Alex Denes MD FACP
1 CommentReloxin vs Botox
Reuters has this press release from French drug maker Ipsen about it's Botox killer, Reloxin:
French drug maker Ipsen's (IPN.PA) anti-wrinkle treatment Reloxin, a possible rival to Allergan's (AGN.N) Botox, reduced forehead wrinkles and had few side effects in a U.S. study published on Monday.
Ipsen said in January the U.S. Food and Drug Administration had extended to April 13 its review of the company's injectable botulinum toxin product for possible approval.
A study involving 1,052 people, published in the Archives of Facial Plastic Surgery, showed that Reloxin improved the appearance of moderate to severe forehead lines.
Within a week, 93 percent to 95 percent of the people in the study responded to the treatment, consisting of five injections at a time, the researchers said. One treatment typically worked for almost three months.
The patients received up to five sets of five injections over the 13 months of the study.
Only one person dropped out of the study due to side effects related to the drug, the researchers said.
Ipsen in 2006 granted Scottsdale, Arizona-based Medicis Pharmaceutical Corp (MRX.N) rights to develop, distribute and commercialize Reloxin in the United States, Canada and Japan for aesthetic use and Medicis funded the study.
The company declined to comment on the findings, citing the ongoing FDA review. The drug is approved for fighting wrinkles in 23 countries, but not the lucrative U.S. market.
"It had a good safety profile and was effective, but we did not do a head-to-head comparison (with Botox). That's the next step, of course, something that probably will be done in the future," said Dr. Ronald Moy of the California Health & Longevity Institute, one of the researchers.
"It will be a good alternative for consumers and may be less expensive," Moy added in a telephone interview.
The drug is made from a toxin made by the bacterium Clostridium botulinum, which also causes botulism food poisoning.
UPDATE:
Medical Spa RX Beta is now online!
We've just launched our new international medical spa pharmacy program with the release of Medical Spa RX, a wholesale pharmacy in Canada that has the lowest price for Botox, Restylane, Juvederm and general products.
Please take a look and consider a test order. We're anxious to provide the very best service and quality through all of our partners and we'll welcome feedback around any issue as we look to imporve the quality of services and make Medical Spa MD the portal for physicians in cosmetic medicine. As part of the innovative services we're offering is the ability to lean on the more than 3500 medical provider members of Medical Spa MD for pricing breaks and special offers.
Among the many unique offerings is the ability to participate in a 'group buy' with group discounting... but wihout the need to organize or oversee the group. I'll be discussing this in detail as it grows.
Anyway, please take a look and consider a small order to test the performance and value.
Reader Comments (1)
thanks so much admin. this is a good post. ı have watching you everyday. this are the best netlog sites of chattube.net and this is the best Chat Sohbet sites of chattube.net . have a nice days see you later ardour team ! and the last one is one of the famous Chat site on google.com. see u later have a nice days.